Investigators studied a novel protein prokineticin 2,also known as Bv8, as a key pro-tumoral factor in colorectal cancer progression in in vitro and ex vivo settings.
[Frontiers in Immunology]
Home Newsletters Intestinal Cell News Bv8 Mediates Myeloid Cell Migration and Enhances Malignancy of Colorectal Cancer
